Bianca Nogrady August 04, 2023 Most cases of virologic failure on dolutegravir treatment for HIV are likely due to adherence problems and more time on treatment is needed before switching to another drug, according to new data from the ADVANCE trial. “What we saw was a faster time to re-suppression in the people followed-up long term on dolutegravir and also a...